TPG ART leads Inocucor Technologies’ $39m Series B
The funds will help fund a new US headquarters, boost production at Inocucor's Montreal pilot production and R&D facility, and increase staff.
The funds will help fund a new US headquarters, boost production at Inocucor's Montreal pilot production and R&D facility, and increase staff.
Copyright PEI Media
Not for publication, email or dissemination